H A Weiss1, S L Thomas, S K Munabi, R J Hayes. 1. MRC Tropical Epidemiology Group, Infectious Disease Epidemiology Unit, Keppel Street, London WC1E 7HT, UK. helen.weiss@lshtm.ac.uk
Abstract
OBJECTIVES: Male circumcision is associated with reduced risk of HIV infection. This may be partly because of a protective effect of circumcision on other sexually transmitted infections (STI), especially those causing genital ulcers, but evidence for such protection is unclear. Our objective was to conduct a systematic review and meta-analyses of the associations between male circumcision and infection with herpes simplex virus type 2 (HSV-2), Treponema pallidum, or Haemophilus ducreyi. METHODS: Electronic databases (1950-2004) were searched using keywords and text terms for herpes simplex, syphilis, chancroid, ulcerative sexually transmitted diseases, or their causative agents, in conjunction with terms to identify epidemiological studies. References of key articles were hand searched, and data were extracted using standardised forms. Random effects models were used to summarise relative risk (RR) where appropriate. RESULTS: 26 articles met the inclusion criteria. Most syphilis studies reported a substantially reduced risk among circumcised men (summary RR = 0.67, 95% confidence interval (CI) 0.54 to 0.83), although there was significant between study heterogeneity (p = 0.01). The reduced risk of HSV-2 infection was of borderline statistical significance (summary RR = 0.88, 95% CI 0.77 to 1.01). Circumcised men were at lower risk of chancroid in six of seven studies (individual study RRs: 0.12 to 1.11). CONCLUSIONS: This first systematic review of male circumcision and ulcerative STI strongly indicates that circumcised men are at lower risk of chancroid and syphilis. There is less association with HSV-2. Potential male circumcision interventions to reduce HIV in high risk populations may provide additional benefit by protecting against other STI.
OBJECTIVES: Male circumcision is associated with reduced risk of HIV infection. This may be partly because of a protective effect of circumcision on other sexually transmitted infections (STI), especially those causing genital ulcers, but evidence for such protection is unclear. Our objective was to conduct a systematic review and meta-analyses of the associations between male circumcision and infection with herpes simplex virus type 2 (HSV-2), Treponema pallidum, or Haemophilus ducreyi. METHODS: Electronic databases (1950-2004) were searched using keywords and text terms for herpes simplex, syphilis, chancroid, ulcerative sexually transmitted diseases, or their causative agents, in conjunction with terms to identify epidemiological studies. References of key articles were hand searched, and data were extracted using standardised forms. Random effects models were used to summarise relative risk (RR) where appropriate. RESULTS: 26 articles met the inclusion criteria. Most syphilis studies reported a substantially reduced risk among circumcised men (summary RR = 0.67, 95% confidence interval (CI) 0.54 to 0.83), although there was significant between study heterogeneity (p = 0.01). The reduced risk of HSV-2 infection was of borderline statistical significance (summary RR = 0.88, 95% CI 0.77 to 1.01). Circumcised men were at lower risk of chancroid in six of seven studies (individual study RRs: 0.12 to 1.11). CONCLUSIONS: This first systematic review of male circumcision and ulcerative STI strongly indicates that circumcised men are at lower risk of chancroid and syphilis. There is less association with HSV-2. Potential male circumcision interventions to reduce HIV in high risk populations may provide additional benefit by protecting against other STI.
Authors: R A Diseker; T A Peterman; M L Kamb; C Kent; J M Zenilman; J M Douglas; F Rhodes; M Iatesta Journal: Sex Transm Infect Date: 2000-12 Impact factor: 3.519
Authors: Stephen Tabet; Jorge Sanchez; Javier Lama; Pedro Goicochea; Pablo Campos; Manuel Rouillon; Jose Luis Cairo; Lucia Ueda; Douglas Watts; Connie Celum; King K Holmes Journal: AIDS Date: 2002-06-14 Impact factor: 4.177
Authors: D W Cameron; J N Simonsen; L J D'Costa; A R Ronald; G M Maitha; M N Gakinya; M Cheang; J O Ndinya-Achola; P Piot; R C Brunham Journal: Lancet Date: 1989-08-19 Impact factor: 79.321
Authors: Steven J Reynolds; Mary E Shepherd; Arun R Risbud; Raman R Gangakhedkar; Ronald S Brookmeyer; Anand D Divekar; Sanjay M Mehendale; Robert C Bollinger Journal: Lancet Date: 2004-03-27 Impact factor: 79.321
Authors: J J Rodrigues; S M Mehendale; M E Shepherd; A D Divekar; R R Gangakhedkar; T C Quinn; R S Paranjape; A R Risbud; R S Brookmeyer; D A Gadkari Journal: BMJ Date: 1995-07-29
Authors: Godfrey Kigozi; Maria Wawer; Absalom Ssettuba; Joseph Kagaayi; Fred Nalugoda; Stephen Watya; Fred Wabwire Mangen; Noah Kiwanuka; Melanie C Bacon; Tom Lutalo; David Serwadda; Ronald H Gray Journal: AIDS Date: 2009-10-23 Impact factor: 4.177